Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European Union. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S2666776226003005?dgcid=rss_sd_all
Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European Union. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S2666776226003005?dgcid=rss_sd_all
“Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European Union.” The Lancet Regional Health - Europe.
@article{article69181,
title = {Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European Union},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S2666776226003005?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...